Marie Sophie Lykke Isidor
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adipocytes, Brown | 8 | 2025 | 45 | 1.550 |
Why?
|
| Thermogenesis | 11 | 2025 | 108 | 1.440 |
Why?
|
| Adipose Tissue, Brown | 9 | 2025 | 100 | 1.230 |
Why?
|
| Insulin Resistance | 3 | 2021 | 404 | 0.780 |
Why?
|
| Adipose Tissue, White | 6 | 2020 | 82 | 0.740 |
Why?
|
| Pyruvate Kinase | 1 | 2019 | 11 | 0.680 |
Why?
|
| Down-Regulation | 2 | 2019 | 305 | 0.660 |
Why?
|
| Adipocytes | 8 | 2025 | 252 | 0.630 |
Why?
|
| Glucose | 6 | 2021 | 444 | 0.490 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 674 | 0.470 |
Why?
|
| Insulin | 4 | 2021 | 687 | 0.330 |
Why?
|
| Cold Temperature | 3 | 2025 | 51 | 0.320 |
Why?
|
| Uncoupling Protein 1 | 5 | 2023 | 47 | 0.310 |
Why?
|
| Mice | 16 | 2025 | 10280 | 0.300 |
Why?
|
| Adipose Tissue | 2 | 2021 | 283 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 7 | 2025 | 3195 | 0.290 |
Why?
|
| Obesity | 4 | 2023 | 1186 | 0.260 |
Why?
|
| Lipolysis | 3 | 2023 | 47 | 0.260 |
Why?
|
| Adipocytes, White | 3 | 2021 | 27 | 0.250 |
Why?
|
| Paracrine Communication | 1 | 2025 | 14 | 0.240 |
Why?
|
| Chemokine CXCL12 | 1 | 2025 | 15 | 0.240 |
Why?
|
| Adipogenesis | 4 | 2020 | 71 | 0.240 |
Why?
|
| Transcriptome | 2 | 2025 | 326 | 0.230 |
Why?
|
| Succinic Acid | 1 | 2024 | 11 | 0.230 |
Why?
|
| Animals | 16 | 2025 | 19663 | 0.220 |
Why?
|
| Appetite Depressants | 1 | 2023 | 4 | 0.220 |
Why?
|
| Ion Channels | 2 | 2013 | 87 | 0.210 |
Why?
|
| Mitochondrial Proteins | 2 | 2013 | 99 | 0.200 |
Why?
|
| Microfilament Proteins | 2 | 2021 | 116 | 0.200 |
Why?
|
| DNA Damage | 1 | 2024 | 280 | 0.200 |
Why?
|
| Lactic Acid | 2 | 2023 | 70 | 0.190 |
Why?
|
| Genomics | 1 | 2024 | 314 | 0.190 |
Why?
|
| Adrenergic beta-Agonists | 2 | 2017 | 29 | 0.180 |
Why?
|
| Glycolysis | 2 | 2017 | 54 | 0.180 |
Why?
|
| Cell Line | 3 | 2020 | 2015 | 0.180 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 127 | 0.170 |
Why?
|
| Histone Deacetylase 6 | 1 | 2019 | 7 | 0.170 |
Why?
|
| Fibroblast Growth Factors | 1 | 2019 | 63 | 0.170 |
Why?
|
| Receptor, Insulin | 1 | 2019 | 47 | 0.160 |
Why?
|
| Cyclooxygenase 2 | 1 | 2019 | 77 | 0.160 |
Why?
|
| Gene Expression | 2 | 2019 | 810 | 0.160 |
Why?
|
| Adiposity | 1 | 2019 | 79 | 0.160 |
Why?
|
| Fatty Liver | 1 | 2019 | 97 | 0.150 |
Why?
|
| Antigens, CD | 1 | 2019 | 344 | 0.150 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2017 | 11 | 0.150 |
Why?
|
| Symporters | 1 | 2017 | 13 | 0.150 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2019 | 255 | 0.150 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 31 | 0.140 |
Why?
|
| Tissue Donors | 1 | 2017 | 133 | 0.140 |
Why?
|
| Oxygen Consumption | 1 | 2017 | 202 | 0.140 |
Why?
|
| Transcription Factors | 3 | 2020 | 1457 | 0.130 |
Why?
|
| Genetic Engineering | 1 | 2017 | 112 | 0.130 |
Why?
|
| Cells, Cultured | 5 | 2021 | 2104 | 0.130 |
Why?
|
| Lipid Metabolism | 2 | 2017 | 200 | 0.130 |
Why?
|
| Diet, High-Fat | 3 | 2021 | 160 | 0.120 |
Why?
|
| Cell Differentiation | 5 | 2020 | 1295 | 0.120 |
Why?
|
| Incretins | 1 | 2013 | 6 | 0.110 |
Why?
|
| Male | 7 | 2025 | 27578 | 0.110 |
Why?
|
| Venoms | 1 | 2013 | 11 | 0.110 |
Why?
|
| Lung Diseases, Obstructive | 1 | 2013 | 20 | 0.110 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2013 | 21 | 0.110 |
Why?
|
| Isoproterenol | 3 | 2017 | 34 | 0.110 |
Why?
|
| Tretinoin | 1 | 2013 | 48 | 0.110 |
Why?
|
| CRISPR-Cas Systems | 1 | 2017 | 327 | 0.110 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2013 | 55 | 0.110 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 1538 | 0.110 |
Why?
|
| Receptors, Estrogen | 1 | 2013 | 124 | 0.100 |
Why?
|
| Peptides | 1 | 2013 | 549 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2021 | 861 | 0.070 |
Why?
|
| Homeostasis | 2 | 2021 | 342 | 0.070 |
Why?
|
| Humans | 8 | 2024 | 59527 | 0.070 |
Why?
|
| Primary Cell Culture | 2 | 2019 | 75 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 1221 | 0.060 |
Why?
|
| Acclimatization | 1 | 2025 | 10 | 0.060 |
Why?
|
| Autocrine Communication | 1 | 2025 | 31 | 0.060 |
Why?
|
| Oxidation-Reduction | 2 | 2017 | 305 | 0.060 |
Why?
|
| Succinates | 1 | 2024 | 8 | 0.060 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2 | 2013 | 30 | 0.050 |
Why?
|
| Basigin | 1 | 2023 | 3 | 0.050 |
Why?
|
| Sodium | 1 | 2023 | 60 | 0.050 |
Why?
|
| Osmolar Concentration | 1 | 2023 | 89 | 0.050 |
Why?
|
| Cell Death | 1 | 2024 | 268 | 0.050 |
Why?
|
| Female | 3 | 2019 | 30924 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2024 | 299 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2021 | 79 | 0.050 |
Why?
|
| Sympathetic Nervous System | 1 | 2021 | 33 | 0.050 |
Why?
|
| COS Cells | 1 | 2021 | 174 | 0.050 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2020 | 18 | 0.050 |
Why?
|
| Subcutaneous Fat | 1 | 2020 | 47 | 0.040 |
Why?
|
| Dietary Fats | 1 | 2021 | 204 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 1373 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2020 | 364 | 0.040 |
Why?
|
| 3T3-L1 Cells | 1 | 2019 | 83 | 0.040 |
Why?
|
| Eosinophils | 1 | 2019 | 52 | 0.040 |
Why?
|
| Proteomics | 1 | 2020 | 252 | 0.040 |
Why?
|
| Apoptosis | 1 | 2024 | 1039 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2024 | 645 | 0.040 |
Why?
|
| Sodium-Bicarbonate Symporters | 1 | 2017 | 2 | 0.040 |
Why?
|
| Colforsin | 1 | 2017 | 24 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2021 | 2891 | 0.040 |
Why?
|
| Telomerase | 1 | 2017 | 30 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 2017 | 97 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2013 | 1470 | 0.040 |
Why?
|
| Body Weight | 1 | 2019 | 378 | 0.040 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 9 | 0.040 |
Why?
|
| Retroviridae | 1 | 2017 | 73 | 0.040 |
Why?
|
| Neck | 1 | 2017 | 46 | 0.040 |
Why?
|
| Phenotype | 1 | 2021 | 1157 | 0.040 |
Why?
|
| Thiazolidinediones | 1 | 2017 | 52 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2021 | 847 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2017 | 109 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2017 | 131 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2020 | 945 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2017 | 194 | 0.030 |
Why?
|
| Hypoxia | 1 | 2017 | 110 | 0.030 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2017 | 85 | 0.030 |
Why?
|
| Biopsy | 1 | 2017 | 375 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2017 | 577 | 0.030 |
Why?
|
| Receptors, Glucagon | 1 | 2013 | 4 | 0.030 |
Why?
|
| Liraglutide | 1 | 2013 | 4 | 0.030 |
Why?
|
| PPAR delta | 1 | 2013 | 9 | 0.030 |
Why?
|
| Benzoates | 1 | 2013 | 9 | 0.030 |
Why?
|
| Mitochondria | 1 | 2017 | 337 | 0.030 |
Why?
|
| Retinoids | 1 | 2013 | 12 | 0.030 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2013 | 20 | 0.030 |
Why?
|
| Ovalbumin | 1 | 2013 | 114 | 0.030 |
Why?
|
| Palmitoylcarnitine | 1 | 2013 | 1 | 0.030 |
Why?
|
| PPAR gamma | 1 | 2013 | 72 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2013 | 28 | 0.030 |
Why?
|
| Species Specificity | 1 | 2013 | 337 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2013 | 65 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2013 | 179 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2013 | 76 | 0.030 |
Why?
|
| Models, Biological | 1 | 2017 | 1142 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 2069 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 851 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2013 | 295 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2013 | 349 | 0.020 |
Why?
|
| Rats | 1 | 2013 | 1913 | 0.020 |
Why?
|
| Biomarkers | 1 | 2013 | 1211 | 0.020 |
Why?
|
| Inflammation | 1 | 2013 | 1102 | 0.020 |
Why?
|